Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Chemical Biology (2)
Nature Communications (1)
Nature Structural & Molecular Biology (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (3)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Diseases
Drug discovery
Medical research
Microbiology
Molecular medicine

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–4 of 4 results

Advanced filters: Author: Donna Baldisseri Clear advanced filters

Author Correction: Evybactin is a DNA gyrase inhibitor that selectively kills Mycobacterium tuberculosis

Yu Imai
Glenn Hauk
Kim Lewis
Amendments and Corrections08 Nov 2024
Nature Chemical Biology

Volume: 20, P: 1701
Ataluren improves hematopoietic and pancreatic disorders in Shwachman-Diamond syndrome patients: a compassionate program case-series

Ataluren restored SBDS protein synthesis in three patients with Shwachman-Diamond syndrome, improving bone marrow cellularity and pancreatic function without side effects, highlighting its potential as therapeutic option for this genetic disease.

Valentino Bezzerri
Anna Pegoraro
Marco Cipolli
ResearchOpen Access02 Sept 2025
Nature Communications

Volume: 16, P: 1-12
Structure of the negative regulatory domain of p53 bound to S100B(ββ)

Richard R. Rust
Donna M. Baldisseri
David J. Weber
Research01 Jul 2000
Nature Structural Biology

Volume: 7, P: 570-574
Evybactin is a DNA gyrase inhibitor that selectively kills Mycobacterium tuberculosis

Evybactin is an antimicrobial natural product that targets DNA gyrase, where it binds to a site overlapping with synthetic thiophene poisons and exerts selectivity for Mycobacterium tuberculosis via its transport mechanism into the cell.

Yu Imai
Glenn Hauk
Kim Lewis
Research22 Aug 2022
Nature Chemical Biology

Volume: 18, P: 1236-1244

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

© 2026 Springer Nature Limited